Doctoral Program for World-leading Innovative & Smart Education
Activity
[Press Release] Mass producing engineered T cells for cancer therapy using Platinum TALEN
August 4, 2026
On July 3, Hiroshima University issued a press release announcing research findings from a research group that includes Ms. TOISHIGAWA Kayo, a fourth-year doctoral student of the Graduate School of Biomedical and Health Sciences, who is enrolled in the Medical Course of the Frontier Development Program for Genome Editing, and Professor ICHINOHE Tatsuo of Research Institute for Radiation Biology and Medicine, who was responsible for the Medical Course.
For more details, please see the following link:
* Affiliations and academic years are as of the time of the research.